Abstract: Stress is an important initiating factor in promoting Alzheimer's disease (AD) pathogenesis. However, the mechanism by which stress induces AD-like cognitive impairment remains to be clarified. Here, we demonstrate that DNA damage is increased in stress hormone Corticotropin-releasing factor (CRF)-treated cells and in brains of mice exposed to chronic restraint stress. Accumulation of DNA damage drives activation of cell cycle checkpoint protein kinase 1 (Chk1), upregulation of cancerous inhibitor of PP2A (CIP2A), tau hyperphosphorylation, and Aβ overproduction, eventually resulting in synaptic impairment and cognitive deficits. Pharmacological intervention targeting Chk1 by specific inhibitor and DNA damage by vitamin C, suppress DNA damage-Chk1-CIP2A signaling pathway in chronic stress animal model, which in turn attenuate AD-like pathologies, synaptic impairments and cognitive deficits. Our study uncovers a novel molecular mechanism of stress-induced AD-like pathologies and provides effective preventive and therapeutic strategies targeting this signaling pathway.
Introduction
Epidemiological studies have long linked chronic stress to an increased risk of Alzheimer’s Disease (AD). While we know that stress hormones like Corticotropin-releasing factor (CRF) impact the brain, the precise "molecular bridge" that triggers the overproduction of Amyloid-beta (Aβ) and the hyperphosphorylation of Tau has remained elusive. This study, published in AGING (2024), investigates whether DNA damage—an early event in AD—is the missing link that activates pathological signaling in mature neurons.
Methods
The researchers employed a multi-tiered approach using both in vivo and in vitro models:
- Animal Models: Three distinct stress paradigms were used: Chronic Unpredictable Mild Stress (CUMS) in rats, Chronic Restraint Stress (CRS) in mice, and Acute Restraint Stress (ARS) in mice.
- Cellular Models: Primary cortical neurons were treated with stress hormones (CRF and Corticosterone) to mimic chronic stress conditions.
- Interventions: To test the pathway, they administered Vitamin C (as an antioxidant to prevent DNA damage) and GDC-0575 (a specific inhibitor of Chk1).
- Analysis: Protein levels were quantified via Western blotting and ELISA. DNA damage was mapped using the marker γH2A.X via immunofluorescence. Cognitive function was assessed through behavioral tests including the Barnes Maze and Novel Object Recognition.
Key Results
Stress-Induced DNA Damage
Chronic stress significantly increased DNA damage across various models. Elevated levels of γH2A.X were observed in both the hippocampus (specifically the CA1 and DG regions) and the cortex. This damage was found almost exclusively in neurons rather than glial cells.
The Chk1-CIP2A Signaling Axis
The accumulation of DNA damage activates Chk1, a protein typically involved in cell cycle management. In non-dividing neurons, this activation triggers the upregulation of CIP2A. CIP2A acts as a "brake failure" for the brain's cleaning mechanisms; it inhibits PP2A, which is responsible for dephosphorylating Tau. This leads to the hyperphosphorylation of Tau and increased Aβ production.
Therapeutic Rescue
Treatment with Vitamin C or the Chk1 inhibitor GDC-0575 successfully suppressed the DNA damage-Chk1-CIP2A signaling pathway. These interventions restored levels of critical synaptic proteins (PSD95 and Synapsin I) and significantly improved cognitive performance in behavioral assays, with treated mice performing nearly as well as control groups.
Discussion and Insights
- Regional Vulnerability: The CA1 region of the hippocampus showed significantly more DNA damage than other areas, explaining why spatial memory is often the first cognitive function to decline under chronic stress.
- Pathway Specificity: Interestingly, while Chk1 inhibition rescued cognitive deficits, it did not significantly alter anxiety or depression-like behaviors. This suggests the DNA damage pathway is a specific driver of neurodegeneration rather than general emotional regulation.
- Clinical Potential: The study identifies Chk1 and DNA damage as viable therapeutic targets for preventing stress-induced AD pathologies.
Limitations and Future Work
This study focused exclusively on male models to minimize hormonal variability; future research must validate these findings in females, who are at higher risk for AD. Additionally, while Vitamin C showed cognitive benefits, its effect on mood-related symptoms was less pronounced, suggesting a need for dose optimization. Moving from mouse restraint-stress models to human clinical applications remains a significant challenge requiring further longitudinal validation.
Summary updated